1301.0000 -20.50 (-1.55%)
NSE Jun 27, 2025 15:31 PM
Volume: 1.8M
 

KRChoksey
In Q2FY24, Dr. Reddy’s reported the highest quarterly revenue and profits. The Company generated revenue of INR 69,026 Mn, which grew by 9.0% YoY and 2.1% QoQ. Global Generics reported revenue of INR 61,084 Mn which is a YoY growth of 9.0%, this growth was mainly driven by North America and Europe.
Dr. Reddy's Laboratories Ltd. is trading above all available SMAs
More from Dr. Reddy's Laboratories Ltd.
Recommended